Roger Adsett

CIK: 0001685904

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)27 (73.0%)

Position reduction

Option Exercises (M)4 (10.8%)

Derivative conversions

Awards (A)6 (16.2%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

INSM

INSMED Inc

Officer

DFTX

Definium Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (37 total)

INSM
INSMED Inc
Aug 10, 2026
Sale(S)
Direct
239.9K shares at avg. $133.27$32.0M
INSM
INSMED Inc
Aug 10, 2026
Exercise(M)
Direct
82.3K shares at avg. $13.67$1.1M
INSM
INSMED Inc
Aug 10, 2026
Exercise(M)
Direct
76.6K shares at avg. $17.16$1.3M
INSM
INSMED Inc
Aug 10, 2026
Exercise(M)
Direct
81K shares at avg. $30.46$2.5M
DFTX
Definium Therapeutics, Inc.
Jun 11, 2026
Award(A)
Direct
3.6K shares-
INSM
INSMED Inc
Jun 3, 2026
Sale(S)
Direct
2.4K shares at avg. $102.27$242K
INSM
INSMED Inc
May 13, 2026
Sale(S)
Direct
5.8K shares at avg. $116.18$678K
INSM
INSMED Inc
Apr 1, 2026
Exercise(M)
Direct
88.1K shares at avg. $14.56$1.3M
INSM
INSMED Inc
Apr 1, 2026
Sale(S)
Direct
6.7K shares at avg. $163.18$1.1M
INSM
INSMED Inc
Apr 1, 2026
Sale(S)
Direct
19K shares at avg. $164.11$3.1M
INSM
INSMED Inc
Apr 1, 2026
Sale(S)
Direct
62.3K shares at avg. $164.95$10.3M
INSM
INSMED Inc
Feb 3, 2026
Sale(S)
Direct
791 shares at avg. $156.17$124K
DFTX
Definium Therapeutics, Inc.
Jan 29, 2026
Award(A)
Stock Option (Right to Buy)
Direct
50K shares-
INSM
INSMED Inc
Jan 8, 2026
Sale(S)
Direct
2.1K shares at avg. $174.17$359K
INSM
INSMED Inc
Jan 7, 2026
Sale(S)
Direct
802 shares at avg. $175.07$140K
INSM
INSMED Inc
Jan 6, 2026
Sale(S)
Direct
1.4K shares at avg. $173.33$248K
INSM
INSMED Inc
Jan 2, 2026
Award(A)
Direct
6K shares-
INSM
INSMED Inc
Aug 19, 2025
Sale(S)
Direct
4.8K shares at avg. $128.27$617K
INSM
INSMED Inc
Aug 19, 2025
Sale(S)
Direct
20.2K shares at avg. $127.42$2.6M
INSM
INSMED Inc
Jun 16, 2025
Sale(S)
Direct
4.2K shares at avg. $99.32$416K
INSM
INSMED Inc
Jun 16, 2025
Sale(S)
Direct
6.5K shares at avg. $98.50$640K
INSM
INSMED Inc
Jun 3, 2025
Sale(S)
Direct
1.9K shares at avg. $71.50$133K
INSM
INSMED Inc
May 15, 2025
Award(A)
Direct
6.5K shares-
INSM
INSMED Inc
May 14, 2025
Sale(S)
Direct
1.9K shares at avg. $65.61$126K
INSM
INSMED Inc
May 13, 2025
Sale(S)
Direct
7.5K shares at avg. $67.81$507K

		Type	Shares	Price		Ownership
Aug 10, 2026	INSM INSMED Inc	Sale(S)	239,850	$133.27	$31,964,810	Direct
Aug 10, 2026	INSM INSMED Inc	Exercise(M)	82,280	$13.67	$1,124,768	Direct
Aug 10, 2026	INSM INSMED Inc	Exercise(M)	76,600	$17.16	$1,314,456	Direct
Aug 10, 2026	INSM INSMED Inc	Exercise(M)	80,970	$30.46	$2,466,346	Direct
Jun 11, 2026	DFTX Definium Therapeutics, Inc.	Award(A)	3,555	-	$0	Direct
Jun 3, 2026	INSM INSMED Inc	Sale(S)	2,370	$102.27	$242,380	Direct
May 13, 2026	INSM INSMED Inc	Sale(S)	5,837	$116.18	$678,143	Direct
Apr 1, 2026	INSM INSMED Inc	Exercise(M)	88,060	$14.56	$1,282,154	Direct
Apr 1, 2026	INSM INSMED Inc	Sale(S)	6,715	$163.18	$1,095,754	Direct
Apr 1, 2026	INSM INSMED Inc	Sale(S)	19,001	$164.11	$3,118,254	Direct
Apr 1, 2026	INSM INSMED Inc	Sale(S)	62,344	$164.95	$10,283,643	Direct
Feb 3, 2026	INSM INSMED Inc	Sale(S)	791	$156.17	$123,530	Direct
Jan 29, 2026	DFTX Definium Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	50,000	-	-	Direct
Jan 8, 2026	INSM INSMED Inc	Sale(S)	2,059	$174.17	$358,616	Direct
Jan 7, 2026	INSM INSMED Inc	Sale(S)	802	$175.07	$140,406	Direct
Jan 6, 2026	INSM INSMED Inc	Sale(S)	1,429	$173.33	$247,689	Direct
Jan 2, 2026	INSM INSMED Inc	Award(A)	5,998	-	$0	Direct
Aug 19, 2025	INSM INSMED Inc	Sale(S)	4,807	$128.27	$616,594	Direct
Aug 19, 2025	INSM INSMED Inc	Sale(S)	20,193	$127.42	$2,572,992	Direct
Jun 16, 2025	INSM INSMED Inc	Sale(S)	4,186	$99.32	$415,754	Direct
Jun 16, 2025	INSM INSMED Inc	Sale(S)	6,500	$98.50	$640,250	Direct
Jun 3, 2025	INSM INSMED Inc	Sale(S)	1,860	$71.50	$132,990	Direct
May 15, 2025	INSM INSMED Inc	Award(A)	6,508	-	-	Direct
May 14, 2025	INSM INSMED Inc	Sale(S)	1,925	$65.61	$126,299	Direct
May 13, 2025	INSM INSMED Inc	Sale(S)	7,482	$67.81	$507,354	Direct

1-25 of 37 transactions

About Adsett Roger

Adsett Roger (SEC CIK 0001685904) files insider reports with the SEC as Chief Operating Officer of INSMED Inc (INSM) and Director of Definium Therapeutics, Inc. (DFTX).

Signal8 holds 19 ownership filings by Adsett Roger (1 Form 3, 18 Form 4), filed between Jan 10, 2025 and Aug 12, 2026. Those filings report 37 transactions, from Jan 7, 2025 to Aug 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Adsett Roger's filings is in BRIDGEWATER, NJ.

Recent filings by Adsett Roger

Aug 10, 2026: Open-market sale of INSM shares (Form 4, code S).
Aug 10, 2026: Option exercises of INSM shares (3 lines, Form 4, code M).
Jun 11, 2026: Grant or award of DFTX shares (Form 4, code A).
Jun 3, 2026: Open-market sale of INSM shares (Form 4, code S).
May 13, 2026: Open-market sale of INSM shares (Form 4, code S).

Other insiders filing for INSMED Inc (INSM)

Koppikar Utpal, Director
Hudson Paul, Director
Brennan David R, Director
SHAROKY MELVIN MD, Director
Flammer Martina M.D., Chief Medical Officer
Lewis William, Chair and CEO

How to read Form 4 transaction codes